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It is estimated by the World 
Health Organization (WHO) that 
3% of the world’s population (194 
million) have diabetes and the 
prevalence is expected to double 
by the year 2025 to 6.3% [1]. 
According to WHO, it is estimat-
ed that there were 88,000 diabet-
ics in Libya the year 2000. This 
prevalence is estimated to reach 
245,000 diabetics by the year 
2030, (see ﬁgure below). In Lib-
ya, according to local epidemio-
logical studies, the prevalence 
for known diabetic patients aged 
over 20 years was 3.8% [2]. As 
50% of type 2 diabetic patients 
are unaware of their diabetes 
“undiagnosed”, the actual preva-
lence is probably higher.
In the town of Tajoura, the west 
part of Libya; 7.9% of all adult 
members of 1094 randomly se-
lected families (2996 persons 
aged between 20 and 75 years) 
had diabetes [3]. 
In Benghazi, in the eastern part 
of Libya, screening of a randomly 
selected group of 868 subjects re-
vealed that about 23% above age 
of 20 years were glucose intoler-
ant, two-thirds had diabetes and 
the rest had impaired glucose tol-
erance [4]. 
From these two Libyan cohorts, 
we estimate the adult diabetic 
population in Libya to be at least 
300,000 at present.Libyan Journal of Medicine, Volume 1, 2006
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Figure showing the estimated preva-
lence of diabetes mellitus of adults in 
2030 as compared with data from the 
year 2000. Reprinted with permission 
from The American Diabetes Associa-
tion. Reference: Diabetes Care, Vol. 
27, 2004; 1047-1053.
In addition, these studies showed 
that only 18% of Libyans practice 
any form of physical exercise and 
more than 69% have a BMI of 
more than 25 kg/m² [3]. The sed-
entary life style and obesity are 
clearly the major contributing fac-
tors for the diabetes epidemic.
The cost of health care: The av-
erage annual heath care cost for 
a patient with type 2 diabetes in 
Sweden is ~ 2700 Euros [5]. 42% 
of this cost was for in hospitali-
sation cost and 31% for ambula-
tory care visits. Only 2% of the 
cost was for anti-diabetic drugs. 
In Spain the direct cost per dia-
betic per capita per year estimat-
ed to be 50% of Swedish cost (~ 
1300 Euros) [6]. In comparison to 
Spain, we estimate at least 400 
million Euros will be needed an-
nually to deliver an optimal dia-
betes care for the 300,000 Libyan 
diabetic population [4, 7, 8].
In summary: This huge diabetic 
load seriously threatens the coun-
try’s health service. However, 
due to differences in standards 
of living, our cost estimates may 
not be appropriate for Libya, and 
carefully planned epidemiologi-
cal and economic studies should 
be seriously considered. Public 
education to increase the physi-
cal activity and to normalize the 
carbohydrate load are important 
actions to be taken to limit the 
diabetes epidemic [9].
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